Evaluating Information and Presenting Risk Today’s Class Fact Sheet Assignment Review Evaluating Information Presenting Risk In-class Activity This week’s.

Slides:



Advertisements
Similar presentations
Appraisal of an RCT using a critical appraisal checklist
Advertisements

LUNG CANCER LUNG CANCER Lung Cancer  What Is Lung Cancer?  Lung Cancer is a disease caused by the rapid growth and division of cells that make up the.
External validity: to what populations do our study results apply?
Understanding Statistics in Research Articles Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant Professor,
Reporting drugs and treatments Thomas Abraham. What we will learn today The difference between absolute and relative risk reduction A basic way to interpret.
Unit 14: Measures of Public Health Impact.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Find the Joy in Stats ? ! ? Walt Senterfitt, Ph.D., PWA Los Angeles County Department of Public Health and CHAMP.
Extension Article by Dr Tim Kenny
Understanding real research 3. Assessment of risk.
Topic 6: Introduction to Hypothesis Testing
Announcements ●Exam II range ; mean 72
Chapter 51 Experiments, Good and Bad. Chapter 52 Experimentation u An experiment is the process of subjecting experimental units to treatments and observing.
ABCWINRisk and Statistics1 Risk and Statistics Risk Assessment in Clinical Decision Making Ulrich Mansmann Medical Statistics Branch University of Heidelberg.
Mathew J. Reeves BVSc, PhD Associate Professor, Epidemiology
Statistics for Health Care
Research Methods in Psychology Pertemuan 3 s.d 4 Matakuliah: L0014/Psikologi Umum Tahun: 2007.
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
Biology in Focus, HSC Course Glenda Childrawi, Margaret Robson and Stephanie Hollis A Search For Better Health Topic 11: Epidemiology.
Are exposures associated with disease?
Epidemiology 101: basic concepts
1. Statistics: Learning from Samples about Populations Inference 1: Confidence Intervals What does the 95% CI really mean? Inference 2: Hypothesis Tests.
© 2015 Evidera. All Rights Reserved. Karin Hawkinson, Scientific Director, Global Market Access Communications Message communication vs. data dumping How.
Medical Statistics (full English class) Ji-Qian Fang School of Public Health Sun Yat-Sen University.
Absolute, Relative and Attributable Risks. Outcomes or differences that we are interested in:  Differences in means or proportions  Odds ratio (OR)
INTRODUCTION TO EPIDEMIOLO FOR POME 105. Lesson 3: R H THEKISO:SENIOR PAT TIME LECTURER INE OF PRESENTATION 1.Epidemiologic measures of association 2.Study.
Multiple Choice Questions for discussion
Testing Hypotheses Tuesday, October 28. Objectives: Understand the logic of hypothesis testing and following related concepts Sidedness of a test (left-,
DrugEpi 1-4 Counting HS Marijuana Use Module 1 Overview Context Content Area: Descriptive Epidemiology & Surveillance Essential Question (Generic): How.
Interpreting numbers – more tricky bits ScotPHO training course March 2011 Dr Gerry McCartney Head of Public Health Observatory Division NHS Health Scotland.
FRAMING RESEARCH QUESTIONS The PICO Strategy. PICO P: Population of interest I: Intervention C: Control O: Outcome.
Please turn off cell phones, pagers, etc. The lecture will begin shortly.
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Measures of Association
Module Overview Risk—what is it? How do we perceive risks-socioecological model? It’s all relative.. Where do health statistics come from? How can I learn.
Decision Support as a Clinical Skill Module V: Communicating Risk Information Last update: September 2008.
Step 3 of the Data Analysis Plan Confirm what the data reveal: Inferential statistics All this information is in Chapters 11 & 12 of text.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
The binomial applied: absolute and relative risks, chi-square.
R Programming Risk & Relative Risk 1. Session 2 Overview 1.Risk 2.Relative Risk 3.Percent Increase/Decrease Risk 2.
RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010.
Thomas Lumley Department of Statistics University of Auckland
Measuring associations between exposures and outcomes
Purpose The purpose of this study was to examine the influence of the terms AND and DNR on decisional conflict in surrogate decision-makers. Decisional.
Fall 2002Biostat Statistical Inference - Proportions One sample Confidence intervals Hypothesis tests Two Sample Confidence intervals Hypothesis.
1 Study Design Issues and Considerations in HUS Trials Yan Wang, Ph.D. Statistical Reviewer Division of Biometrics IV OB/OTS/CDER/FDA April 12, 2007.
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 10 Comparing Two Groups Section 10.1 Categorical Response: Comparing Two Proportions.
Compliance Original Study Design Randomised Surgical care Medical care.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Discussing numerical data with patients. Framing Framing manipulations: describing equivalent choice situations in different ways Information on relative.
Copyright © 2016 The McGraw-Hill Companies, Inc. Permission required for reproduction or display. D ESIGN OF E XPERIMENTS Section 1.3.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
HelpDesk Answers Synthesizing the Evidence
Confidence Intervals and p-values
The binomial applied: absolute and relative risks, chi-square
Interpreting numbers – more tricky bits
Critical Reading of Clinical Study Results
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
remember to round it to whole numbers
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
1 Information Mastery Skills Calculating RR, RRR, ARR and NNTs A. Bornstein, MD, FACC Assistant Professor of Medicine Weil Cornell Medical College New.
Interpreting Basic Statistics
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Measures of risk and association
Presentation transcript:

Evaluating Information and Presenting Risk

Today’s Class Fact Sheet Assignment Review Evaluating Information Presenting Risk In-class Activity This week’s homework

Fact Sheet Assignment Well done! –Nice use of headers, bullets, etc to organize content –Good sources –Appropriate use of plain language

Fact Sheets Be Mindful –Avoid clinical language “sleep disturbances” “menstruation” –Provide intro text before a bulleted list “Symptoms of iron deficiency anemia include the following:” –Make sure your bullets are consistent Formatting (bold, hyphens, etc.) Structure (all phrases or sentences, start with verb or noun, etc.)

Evaluating Information Consider the source Determine if information is consistent within the source and with other sources? Consider the study design

HealthNewsReview.org When reporting about a treatment or test, be sure to: –Discuss cost –Describe how big (or small) are the potential benefits AND harms –Use absolute (not just relative) risk/benefit data –Compare the new idea with existing alternatives –Seek out independent sources, with no conflicts of interest –Look beyond the news release

HealthNewsReview.org (continued) When reporting about a treatment or test, be sure to: –Avoid disease mongering - exaggerating or medicalizing conditions –Remember (and remind your readers) that not all studies are equal –Note whether it’s really a new idea or just new wrapping on an old idea –Explain whether/how widespread it’s available (or is it years away?)

Before we talk about risk, a a bit about numbers Do the math, if you can Give a visual –“size of a football field” Use comparable forms –3/4 (fraction) vs. 75% (percentage) vs. 75 (absolute) Use sparingly –Only two sets of numbers per sentence Avoid excessive detail Report only statistically significant numbers (or clarify)

Risk To the scientific community, risk is a statistical concept of probability –The likelihood that a given event will occur under certain circumstances For public, it is infused with emotion

When Presenting Risk Clarify the outcome under consideration –What are you talking about (getting disease vs. dying)? –Is the outcome a composite or intermediate outcome? –What is the time frame? Provide context –How dangerous (lethality) –Compare your risks to the average person –Compare this risk to other risks –Compare risks alongside benefits

When Presenting Risk (continued) Consider framing risk in more than one way –1 out of 100 had X –99 out of 100 did not have X State treatment alternatives Review measures for controlling risk Highligh study limitations

Use Absolute Risk Simplest way to represent results is by providing absolute event rates for the various exposure groups –Number who experienced outcome/number in group –“The 10-year risk of death was 10% (10 in 100) in patients receiving drug A and 20% (20 in 100) in patients receiving placebo.” Give numerator and denominator if you can Translate percentages less than 1 to frequencies (X in 1000) and use a constant denominator

Interpreting Absolute Risk No interpretation required –X out of 100 patients in the new drug group got sick compared with Y out of 100 patients in the placebo group.

What about relative risk? RR indicates the likelihood of developing a given condition. RR is the absolute risk in exposed / absolute risk in unexposed –Group A 10% (10 out of 100 got sick) –Group B 20% (20 out of 100 got sick) –(10/100) / (20/100) = 0.5 (50%)

Interpreting Relative Risk RR > 1.0 –exposure increases the chance of the outcome RR < 1.0 –exposure decreases the chance of the outcome RR = 1.0 –exposure is not related to the outcome

Interpreting Relative Risk Relative risk < 1 (RR reduction) –1- RR = 0.40 x 100 = 40% lower = 0.77 x 100 = 77% lower Relative risk > 1 –RR = 0.25 x 100 = or 25% higher –For RR greater than 2, just use the RR with “times the risk” RR=2.5 (2.5 times the risk)

Relative Risk Pitfall Well-described finding that RR appears more impressive than corresponding absolute risk reduction Reporting relative risk reductions without specifying event rates leads readers to overestimate the magnitude of findings StudyGroup A Event rate Group B Event rate RR Reduction Clinical Importance? 110%20%50%Yes %0.0002%50%? Large samples make small effects statistically significant

Increases or Decreases Risk? RR = 0.8 RR = 10.0 RR = 1.5 RR = 0.4

Increases or Decreases Risk? RR=0.8 for heart disease following new therapy vs. controls –Patients taking new therapy have a __% higher/lower risk for heart disease than controls RR=10.0 for lung cancer in smokers vs. non- smokers –Smokers have __ times the risk for lung cancer as non-smokers

Increases or Decreases Risk? RR=1.5 for cancer in patients taking new drug versus those not taking it RR=0.4 for stroke in patients taking new drug versus placebo

When to Use Relative Risk? RR is an efficient way to summarize two numbers or make comparisons across treatments or studies –RR for death was 0.9 for drug X, 0.7 for drug Y, and 0.3 for drug Z. Unless absolute risks are given, RRs are incomplete information about effect size

For All Risks Be clear about three things: –Exactly what the outcome is (having a heart attack) –Over what time period the outcome occurred (5 years) –In whom (adults with diabetes)

Activity Read the abstract of the provided study Together complete the RCT study worksheet

Homework Reading assignment –Gastel ch. 7 (pgs ) –“How do U.S. journalists cover treatments, tests, and procedures.” Writing assignment –Write a 250-word summary of a research study –Summary is due by 5:30 pm, Feb. 24 by No class next week, but homework still due